Viral Pneumonia: From Influenza to COVID-19
Abstract
Respiratory viruses are increasingly recognized as a cause of community-acquired pneumonia (CAP). The implementation of new diagnostic technologies has facilitated their identification, especially in vulnerable population such as immunocompromised and elderly patients and those with severe cases of pneumonia. In terms of severity and outcomes, viral pneumonia caused by influenza viruses appears similar to that caused by non-influenza viruses. Although several respiratory viruses may cause CAP, antiviral therapy is available only in cases of CAP caused by influenza virus or respiratory syncytial virus. Currently, evidence-based supportive care is key to managing severe viral pneumonia. We discuss the evidence surrounding epidemiology, diagnosis, management, treatment, and prevention of viral pneumonia.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Related Papers
- Misalignment between Clinical Mold Antigen Extracts and Airborne Molds Found in Water-damaged HomesAnnals of the American Thoracic Society · 2021 · 1 shared tag
- Microbiological Analysis of Indoor Air in Selected Primary Schools: Health Concerns and RecommendationsJournal of Multidisciplinary Science MIKAILALSYS · 2023 · 1 shared tag
- Exposures in the Indoor Environment and Prevalence of Allergic Conditions in the United States of AmericaInternational Journal of Environmental Research and Public Health · 2021 · 1 shared tag
- Dampness, mould, onset and remission of adult respiratory symptoms, asthma and rhinitisEuropean Respiratory Journal · 2019 · 1 shared tag
- Impact of Epidemic Intelligence Service Training in Occupational Respiratory EpidemiologyATS Scholar · 2023 · 1 shared tag
- Streptomyces albireticuli lung infection managed as a pulmonary air cyst: a case report and literature reviewFrontiers in Cellular and Infection Microbiology · 2024 · 1 shared tag